PubRank

Richard C Mulligan

Author PubWeight™ 80.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 2002 15.55
2 Engineering vascularized skeletal muscle tissue. Nat Biotechnol 2005 7.73
3 TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc Natl Acad Sci U S A 2004 4.60
4 Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. Immunity 2004 3.35
5 VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. Nat Med 2006 2.67
6 Exogenous control of mammalian gene expression through modulation of RNA self-cleavage. Nature 2004 2.48
7 Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow. Blood 2005 2.48
8 Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003 2.27
9 Failure of bone marrow to reconstitute lung epithelium. Am J Respir Cell Mol Biol 2005 2.26
10 Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proc Natl Acad Sci U S A 2006 2.17
11 Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation. Mol Ther 2005 1.99
12 Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci U S A 2004 1.98
13 Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor Flk1. Cancer Biol Ther 2002 1.67
14 Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect. Neurosurgery 2006 1.51
15 Recombinant adeno-associated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation. J Neurosurg 2010 1.50
16 Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell. Clin Cancer Res 2007 1.44
17 Genetically engineered T cells to target EGFRvIII expressing glioblastoma. J Neurooncol 2009 1.40
18 Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. Blood 2002 1.35
19 Exogenous control of mammalian gene expression via modulation of translational termination. Nat Med 2006 1.30
20 Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells. J Clin Invest 2013 1.30
21 Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J Clin Invest 2008 1.29
22 Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis. Proc Natl Acad Sci U S A 2008 1.20
23 Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors. Proc Natl Acad Sci U S A 2002 1.20
24 A novel stem-cell population in adult liver with potent hematopoietic-reconstitution activity. Blood 2005 1.10
25 Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages. J Clin Invest 2009 1.09
26 A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C. Brain 2012 1.08
27 Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells. J Biol Chem 2004 1.04
28 Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice. Surgery 2002 1.04
29 Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries. RNA 2006 0.99
30 Imaging phonological similarity effects on verbal working memory. Neuropsychologia 2007 0.97
31 Effects of nicotine withdrawal on verbal working memory and associated brain response. Psychiatry Res 2010 0.92
32 Engineering high-speed allosteric hammerhead ribozymes. Biol Chem 2007 0.92
33 Genetic interventions for vein bypass graft disease: a review. J Vasc Surg 2002 0.90
34 Nitric oxide is a regulator of hematopoietic stem cell activity. Mol Ther 2004 0.90
35 Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients. Oncoimmunology 2012 0.87
36 Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors. Transpl Immunol 2004 0.86
37 Effects of HIV and early life stress on amygdala morphometry and neurocognitive function. J Int Neuropsychol Soc 2012 0.84
38 Consequences of Shb and c-Abl interactions for cell death in response to various stress stimuli. Exp Cell Res 2006 0.82
39 Gene therapy for pancreatic cancer. Surg Oncol Clin N Am 2002 0.81
40 Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation. J Neurosurg 2008 0.81
41 A mammalian cell-based assay for screening inhibitors of RNA cleavage. Methods Mol Biol 2009 0.77
42 A fMRI Study of Verbal Working Memory, Cardiac Output, and Ejection Fraction in Elderly Patients with Cardiovascular Disease. Brain Imaging Behav 2009 0.77
43 Chimeric T-cell Receptor Therapy for Glioblastoma Multiforme 895. Neurosurgery 2006 0.75